Program Schedule

8
Special Plenary Session: Resource-Limited Health Care Issues

Wednesday, October 8, 2014: 3:45 PM-6:15 PM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the impact of novel ideas, research, policy and practices on 21st Century Global Health
  • summarize the global burden of HIV, TB and HPV in adolescence
  • outline intervention techniques at the individual and population levels

Target Audience: Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Medical students and residents, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Hospital administrators, HIV specialists, HIV clinicians, Health care workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Rochelle Walensky, MD, MPH, FIDSA, Massachusetts General Hospital , Robert Read, MD, FIDSA, University of Sheffield and Sheffield Teaching Hospitals Sheffield , James M. Hughes, MD, FIDSA, Emory University and Tina Tan, MD, FIDSA, Northwestern University Feinberg School of Medicine

Presentations:
3:45 PM
Introductory Remarks and Awards
Barbara Murray, MD, FIDSA
4:30 PM
Introductory Remarks and Awards
Daniel J. Diekema, MD, FIDSA, FSHEA
4:30 PM
Introductory Remarks and Awards
David W. Kimberlin, MD, FIDSA
4:30 PM
Introductory Remarks and Awards
Joel Gallant, MD, MPH, FIDSA
4:30 PM
4:30 PM
Recipient of the SHEA Investigator Award
Anthony D. Harris, MD, MPH
4:30 PM
5:15 PM
26

CME Credits: Maximum of 2 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 2.0 knowledge-based contact hours (0.2 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-093-L04-P

Disclosures:

R. Walensky, None

R. Read, None

J. M. Hughes, None

T. Tan, Merck Labs: Grant Investigator and Scientific Advisor, Research grant
Sanofi Pasteur: Consultant, Grant Investigator and Scientific Advisor, Educational grant, Research grant and Speaker honorarium
GSK: Consultant and Scientific Advisor, Consulting fee
Pfizer Wyeth: Scientific Advisor, Consulting fee
Biota: Scientific Advisor, Consulting fee

J. Farrar, None

L. G. Bekker, None

B. Ribner, None

D. J. Diekema, Forest Labs: Grant Investigator, Research grant

J. Gallant, Bristol-Myers Squibb: Investigator, Research support
CytoDyn, Ltd.: Investigator, Research support
Gilead Sciences: Investigator and Scientific Advisor, Consulting fee and Research support
Merck & Co.: Investigator and Scientific Advisor, Consulting fee and Research support
Takara Bio, Inc.: Scientific Advisor, Consulting fee
Sangamo BioSciences: Investigator, Research support
Vertex Pharmaceuticals: Investigator, Research support
ViiV Healthcare: Investigator, Research support
Janssen Therapeutics: Scientific Advisor, Consulting fee

M. Blaser, None

J. Currier, None

E. Tuomanen, None

See more of: Plenary Session

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek